Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
594 JPY | -0.34% |
|
+0.17% | +19.76% |
Jul. 02 | Revive Therapeutics Ltd. Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure | CI |
May. 27 | Nac Co., Ltd. acquired Shuwa Juken, K.K. from Yoshikatsu Gomura. | CI |
MarketScreener Editorial Features
- Stock Market
- Equities
- 9788 Stock
- News Nac Co., Ltd.
- MarketScreener Editorial Features